Literature DB >> 12626547

Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells.

Stefan Klein-Hessling1, Mithilesh Kumar Jha, Brigitte Santner-Nanan, Friederike Berberich-Siebelt, Thomas Baumruker, Anneliese Schimpl, Edgar Serfling.   

Abstract

Treatment of Th cells with compounds that elevate cAMP levels augments Th2-type lymphokine expression, in particular the synthesis of IL-5. Using primary murine CD4(+) T lymphocytes, we show in this study that inhibition of protein kinase A (PKA) activity in Th2 effector cells impairs IL-5 synthesis, whereas the expression of PKA catalytic subunit alpha enhances IL-5 synthesis in Th0 cells. In addition, we observed by coexpression of PKA catalytic subunit and GATA-3 in Th1 cells that the stimulatory effect of PKA is dependent on GATA-3 activity. These data demonstrate that activation of PKA in Th effector cells induces the IL-5 gene expression in a GATA-3-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626547     DOI: 10.4049/jimmunol.170.6.2956

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Computational identification of gene-social environment interaction at the human IL6 locus.

Authors:  Steven W Cole; Jesusa M G Arevalo; Rie Takahashi; Erica K Sloan; Susan K Lutgendorf; Anil K Sood; John F Sheridan; Teresa E Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

2.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

3.  A physical/psychological and biological stress combine to enhance endoplasmic reticulum stress.

Authors:  Tapan Kumar Mondal; Rebecca T Emeny; Donghong Gao; Jeffrey G Ault; Jane Kasten-Jolly; David A Lawrence
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-21       Impact factor: 4.219

4.  NFκB attenuates IL-5 production and upregulates T-box transcription factors in Th2-like T cells.

Authors:  Masaaki Hashiguchi; Ayano Kobayashi; Yuji Kashiwakura; Hidefumi Kojima; Yumiko Kanno; Akira Kurosu; Shogo Tokudome; Tetsuji Kobata
Journal:  Cytotechnology       Date:  2013-08-11       Impact factor: 2.058

5.  Cyclic AMP-induced chromatin changes support the NFATc-mediated recruitment of GATA-3 to the interleukin 5 promoter.

Authors:  Stefan Klein-Hessling; Tobias Bopp; Mithilesh K Jha; Arthur Schmidt; Shoichiro Miyatake; Edgar Schmitt; Edgar Serfling
Journal:  J Biol Chem       Date:  2008-09-04       Impact factor: 5.157

6.  Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells.

Authors:  Ana C Liberman; Maria Antunica-Noguerol; Viviane Ferraz-de-Paula; Joao Palermo-Neto; Carla N Castro; Jimena Druker; Florian Holsboer; Marcelo J Perone; Sarah Gerlo; Karolien De Bosscher; Guy Haegeman; Eduardo Arzt
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

7.  Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.

Authors:  Ligia Chialda; Meixia Zhang; Kay Brune; Andreas Pahl
Journal:  Respir Res       Date:  2005-04-15

8.  The AGC kinase inhibitor H89 attenuates airway inflammation in mouse models of asthma.

Authors:  Laurent L Reber; François Daubeuf; Simona Nemska; Nelly Frossard
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling.

Authors:  Silvia Rossi Paccani; Marisa Benagiano; Nagaja Capitani; Irene Zornetta; Daniel Ladant; Cesare Montecucco; Mario M D'Elios; Cosima T Baldari
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

10.  Animal models of chronic experimental asthma - strategies for the identification of new therapeutic targets.

Authors:  Michael Wegmann
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.